Company intelligence / Profile preview
Reckitt
- Ownership
- Public · RKT
- Development stage
- Other
Overview
Reckitt is a global consumer goods company with a significant healthcare portfolio that includes OTC medications and consumer health products. Their health brands have shown strong performance with 5% LFL growth in OTC brands in 2018[10].
- Therapeutic areas
- GastroenterologyNeurologyInfectious Diseases
- Modalities
- Over-the-counter medicationsConsumer health products
- Industry
- Biotech
Drug pipeline
24 assets23 more assets in the full pipeline.
Financials
- Market cap
- $46.5B
- Total revenue
- $19B
- Enterprise value
- $58.9B
Beyond the preview
Go deeper on Reckitt.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reckitt.